1. A single optogenetic cortex-mediated circuit activation modulated improvement of dysfunction
To evaluate whether the cortical excitatory projections modulate motor function after ischemic stroke, mice received viral infection with AAV2/1-CaMKIIa-ChR2-eYFP or AAV2/1-CaMKIIa-eYFP followed by implantation with an optical fiber over the core region of the injection site (CT-chR2 or CT-eYFP mice, Figure 1B). It was observed that arborization of corticostriatal axons expressing eYFP throughout much of the striatum (Figure 1C and D, and S1). All mice received optostimulation (473 nm, 20 ms width, firing at 10 Hz) during behavioral tests on the 14th day after ischemic stroke.
Two weeks after ischemic stroke, the mice were assessed for alterations in motor activity and anxiety-likely behavior in response to the optogenetic activation of the cortex-mediated circuit. In the open field test, the optogenetic session included five 3-min periods, with the first, third and fifth periods as the light-OFF periods and the second and fourth periods as the light-ON periods (Figure 1E). This motor-evoked response evoked was immediately following light onset. CT-chR2 mice reliably exhibited transient increases in the average speed and the distance in the center compared with the CT-eYFP group during the light-ON periods (average speed: the second period p=0.0182, the fourth period p=0.0002; distance in the center: the second period p=0.0498, the fourth period p<0.0001) (Figure 1F and G). In the fourth period during the light-ON period, the time spent on mobility within the total open field area exhibited an obvious enhancement in the ST-chR2 mice compared with that of ST-eYFP mice (p=0.0152), and there was no significant difference between the CT-chR2 and CT-eYFP groups in the second period (p=0.2492, n=6/group) (Figure 1H). Those results suggested increased motor activity and improved anxiety-likely behavior in ischemic mice with optogenetic activation of the cortex-mediated circuit.
2. A single optogenetic corticostriatal activation modulated improvement of dysfunction
Additionally, in a separate group of mice, we investigated the effect of photostimulation (473 nm, 20 ms width, firing at 10 Hz) on corticostriatal circuit by injecting virus with AAV2/1-CaMKIIa-ChR2-eYFP or AAV2/1-CaMKIIa-eYFP in the cortex and implanting an optical fiber in the dorsal striatum on the 14th day before MCAO surgery (ST-chR2 or ST-eYFP mice, Figure 2B and C).
In the open field test, the optogenetic session included five 3-min periods. Similarly, compared with ST-eYFP mice, photostimulation of ST-chR2 mice remarkably evoked transient increases in the distance traveled in the center area during the light ON periods (the second period, p=0.0852; the fourth period, p=0.0164). This response evoked by the motor was immediately after light onset and was more evident during the fourth period, although there was no significant difference between ST-chR2 and ST-eYFP in the second period (Figure 2D). We also found that the average speed during the light-ON periods was greater than that of ST-eYFP mice (the second period, p=0.1597; the fourth period, p=0.0126) (Figure 2E). Furthermore, ST-chR2 mice also spent more time in mobility during the light-ON period than ST-eYFP mice (the second period, p=0.0090; the fourth period, p=0.0004) (Figure 2F). Surprisingly, in the fifth period (light-OFF), the time spent in mobility also exhibited a remarkable upregulation in the ST-chR2 mice compared with that of ST-eYFP mice, and it might involve repeated optostimulation (p=0.0020, n=6/group) (Figure 2F).
In the foot fault test, the optogenetic session included three periods, with the first and third periods as the light-OFF periods and the second periods as the light-ON period. Compared with the ST-eYFP mice, ST-chR2 mice also evoked transient improvement in partial placement during the light-ON period (P=0.0174) (Figure 2G). Moreover, during the light-ON period, photostimulation resulted in a decrease in the percentage of partial placement speed relative to the first period in the ST-chR2 mice (p=0.0005), whereas no significant difference was observed in the ST-eYFP mice (p=0.6449, n=6/group) (Figure 2H). Thus, a single optogenetic corticostriatal activation modulated improvements of dysfunction after ischemic stroke.
3. Corticostriatal projection regulated the GABA levels of the striatum
To evaluate the mechanism of corticostriatal projection modulating function recovery, we further assessed the levels of neurotransmitters on the 14th day after ischemic stroke (Figure 2I and J, and Figure S2). Compared with the ST-eYFP group, optogenetic corticostriatal stimulation alone significantly reduced the glutamate levels (p=0.0002) and enhanced the GABA levels (p=0.0002) in the ST-chR2 group (Figure 2I and J). Nevertheless, there was no significant difference in ACH, NE, or DA between the ST-chR2 and ST-eYFP groups (p>0.05, n=4/group) (Figure S2). Thus, neurotransmitter changes in the striatum might exert an important role in the activation of corticostriatal circuit-modulated functional recovery.
4. Exercise training improved dysfunction.
The survival of the mice in each group was recorded daily within 14 days after stroke (Figure 3B). Mice from the sham group showed 100% survival during the 14-day observation period. No significant difference in survival was found between the Spont and EX groups at the end of the experiment (p=0.996). Within the entire experimental period, no significant differences were observed in body weight between the Spont and EX groups (p=0.6506, n=7/group) (Figure 3C).
To investigate the effect of exercise, we evaluated the recovery of motor and anxiety-likely behavior after ischemic stroke by behavioral tests, including foot fault test, open field test and rotarod test (Figure 3D-F). In the foot fault test, compared with Sham group, the partial placement of the affected forelimb in Spont and EX groups was markedly increased on the 3th and 7th days after stroke (p<0.0001). No significant difference was observed between the Spont and EX groups on the 3th and 7th day after stroke (p>0.05). After exercise, the dysfunction in the EX group was reversed compared with that of the Spont group on the 14th day after stroke (p=0.0301, n=7/group), suggesting exercise-induced improvement of motor function (Figure 3D).
Consistently, in the rotarod test, compared with the sham group, obvious dysfunction was found in the Spont and EX groups on the 3th and 7th days after stroke (p<0.0001). However, on the 14th day after stroke, better performance was found in the EX group than in the Spont group (p=0.0366), although no significant effect was observed on the 7th day after stroke (p=0.6284, n=7/group), suggesting exercise-induced improvement of motor function (Figure 3E).
In addition, in the open field test, distance in the center area of open field was evaluated to assess the effect of exercise on anxiety-likely behavior (Figure 3F). Although there was no significant difference between the Spont and EX groups on the 7th day after stroke (p=0.9650), a significantly increased distance in the center area was found in the EX group on the 14th day after ischemic stroke (p=0.0125, n=7/group), suggesting exercise-induced improvement of anxiety-likely behavior.
Those results suggested that exercise training can facilitate improvement of motor function and anxiety-likely behavior, although the no significant changes in coordinated function.
5. Repeated optogenetic corticostriatal stimulation modulates exercise-induced functional recovery.
We first evaluated whether the dorsal striatum-projecting subpopulation of cortical glutamatergic neurons exerts an important role in the recovery of exercise-induced dysfunction. Mice received viral infection with AAV2/1-CaMKIIa-ChR2-eYFP (ChR2), AAV2/1-CaMKIIa-eYFP (eYFP, control) or AAV2/1-CaMKIIa-ArchT-eYFP (ArchT) followed by implantation with an optical fiber in the dorsal striatum on the 14th day before MCAO surgery (Figure 4B). The mortality of each group was recorded daily for 14 days after stroke (Figure 4C). On the 14th day after stroke, EX-eYFP showed 80.2% survival within the whole experimental period, 73.4% survival in the EX-chR2 group and 68.6% survival in the Spont-eYFP and EX-ArchT groups. The Spont and EX-ArchT groups showed an increased mortality rate compared with the EX-eYFP and EX-chR2 groups, but the difference was not significant. In addition, for the entire experimental period, there were no significant differences in body weight among the EX-eYFP, EX-chR2, Spont-eYFP, and EX-ArchT groups (n=7/group) (Figure 4D).
In the foot fault test, compared with EX-eYFP, motor function also showed poorer recovery in the EX-ArchT group on the 14th day after ischemic stroke (p=0.0002), which was as long as that of the Spont-eYFP group (p=0.7645). In the EX-chR2 group, repeated corticostriatal activation showed the same recovery rates as that of the EX-eYFP group on the 14th day after ischemic stroke (p>0.999, n=7/group) (Figure 4E-F). Thus, blockade of corticostriatal projections can eliminate exercise-induced fine motor functional recovery.
In the rotarod test, exercise training induced a significant increase in latency to fall in the EX-eYFP group on the 14th day compared with the Spont-eYFP group (p=0.0405). In the EX-eYFP group, the same recovery rate was found as that of the EX-chR2 group (p=0.9998). Nevertheless, compared with the EX-eYFP group, repeated corticostriatal inhibition failed to result in significant changes in motor function in the EX-ArchT group (p>0.999, n=7/group) (Figure 4G-H). Thus, blockade of corticostriatal projections is not sufficient to eliminate motor recovery in coordinated function after exercise intervention.
Anxiety-likely behavior in ischemic mice was evaluated using the open field test. On the 14th day after ischemic stroke, repeated corticostriatal activation induced an increase in the distance in the center in the EX-chR2 group compared with that in the EX-ArchT (p=0.0174) and Spont-eYFP (p<0.0001) groups. No significant difference was found between the EX-chR2 and EX-eYFP groups, although EX-chR2 mice showed increased distance in the center (p=0.3711). Furthermore, anxiety-likely behavior in the EX-eYFP group was not sufficient to significantly improve in comparison to EX-ArchT groups on the 14th day after ischemic stroke (p=0.4833, n=7/group) (Figure 4I-J). Thus, blockade of corticostriatal projections can inhibit exercise-induced anxiety-likely behavior.
Those results suggested that the glutamatergic projections from cortical neurons to the dorsal striatum are crucial to the exercise-induced improvement of motor function and anxiety-likely behavior, although the no significant changes in coordinated function.
6. Exercise training facilitated synaptic plasticity in the striatum
Transcriptome-wide RNA-seq technology was used to explore the mechanism by which exercise facilitates functional recovery. We found 703 DEGs with 300 upregulated genes and 403 downregulated genes between the EX and Spont groups (Figure 5A). We further characterized the biological functions of DEGs using GO analysis and KEGG enrichment analysis. In the top 20 functions of significant enrichment, the most biological-process-related genes were associated with “synaptic transmission, GABAergic”, “regulation neurotransmitter level”, “regulating synaptic organization”, “gamma-aminobutyric acid signaling pathway”, and “modulation of chemical synaptic transmission” in the GO analysis (Figure 6C). These results indicated that the potential mechanism of exercise-induced functional recovery was highly related to the regulation of synaptic plasticity (n=3). To evaluate the results of RNA-seq, we further assessed the levels of synaptic plasticity-associated proteins in the striatum on the 14th day after ischemic stroke (Figure 5D-F). Compared to Spont mice, the Synaptophysin (p=0.0027) and PSD95 (p=0.0101) levels were significantly increased in the EX mice. Thus, exercise training can facilitate synaptic plasticity by enhancing expression of Synaptophysin and PSD 95.
7. Exercise training increased GABA levels of the striatum
We further assessed the levels of neurotransmitters on the 14th day after ischemic stroke (Figures 6 and S3). After exercise, mice showed significantly decreased glutamate levels (p=0.0063) and increased GABA levels (p=0.0071) in the striatum relative to Spont group (Figure 6A and B), which is consistent with optostimulation of corticostriatal circuit. Nevertheless, there was no significant difference in ACH, NE, or DA between the Spont and EX groups(p>0.05, n=4/group) (Figure S3). These results definitively demonstrated that exercise training regulates GABA levels in the striatum which might involve activating the corticostriatal circuit. Thus, neurotransmitter changes in the striatum might exert an important role in exercise-induced functional recovery.
8. GABA receptor antagonist bicuculline eliminated exercise-induced functional recovery.
We next further evaluated the role of GABA in the dorsal striatum in exercise-induced recovery after ischemic stroke. Therefore, we selected bicuculline, a GABA-A receptor antagonist, to suppress the receptor activity in the dorsal striatum (Figure 7B). There was no significant difference in mortality or body weight among the EX, Spont, EX-BICU and EX-Vehicle groups within the whole observation period (Figure 7C and D).
In the foot fault test, the results indicated that, compared with the EX group, partial placement was significantly increased in the Spont group (p=0.0276) on the 14th day after stroke. Even given the treatment of exercise training, mice in the EX+BICU group showed an elevation in partial placement that approached significance in comparison to the EX+Vehicle (p=0.0045) and EX (p=0.0023) groups on the 14th day after stroke. Compared with the Spont group, the EX-Vehicle group showed obvious improvement in motor performance at the same recovery rates as the EX group on the 14th day after ischemic stroke (p=0.9962). No difference was observed between the Spont and EX-BICU groups, suggesting the inhibitory effect of bicuculline on the recovery of fine motor skill in mice with ischemic stroke (p=0.8191) (Figure 7E and F). Thus, blockade of GABA-A receptors in the dorsal striatum can eliminate exercise-induced motor recovery.
In the rotarod test, compared with the Spont group, the latency to fall was obviously improved in the EX (p=0.0419) and EX-Vehicle (p=0.0445) groups on the 14th day after ischemic stroke. No difference was observed between the EX and EX+Vehicle groups (p>0.999). However, bicuculline appeared to not affect coordinated function in the EX-BICU group, similar to the EX-Vehicle group (p=0.2037) (Figure 7G and H). Thus, blockade of GABA-A receptors in the dorsal striatum is not sufficient to inhibit exercise-induced motor recovery in coordinated function.
In the open field test, the results indicated significant effects of bicuculline in inhibiting exercise-induced functional recovery. The distance in center area was significantly increased in the EX group relative to Spont group, suggesting exercise-induced improvement of anxiety-likely behavior (p=0.0484). There was no significant difference between the Spont and EX-BICU groups (p=0.9997, n=7/group). Compared with the Spont group, distance in center area was also obviously increased in the EX (p=0.0484) and EX+Vehicle groups (p=0.0280). There was no significant difference between the EX and EX+Vehicle groups (p=0.9963). Mice in the EX (p=0.0612) and EX+Vehicle groups (p=0.0360) tended to have more free movement in the distance traveled in the center than the EX+BICU group on the 14th day after ischemic stroke. (Figure 7I-J). Thus, blockade of GABA-A receptors in the dorsal striatum can eliminate exercise-induced motor recovery.
Those results suggested that the GABA-A receptors in the dorsal striatum are essential to exercise-induced motor functional recovery, although the no significant changes in coordinated function.